Casdin Capital, LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $1.29 Billion distributed in 35 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Biolife Solutions Inc with a value of $218M, Revolution Medicines, Inc. with a value of $186M, Standard Biotools Inc. with a value of $138M, Sarepta Therapeutics, Inc. with a value of $134M, and Illumina, Inc. with a value of $97.8M.
Examining the 13F form we can see an increase of $128M in the current position value, from $1.16B to 1.29B.
Casdin Capital, LLC is based out at New York, NY
Below you can find more details about Casdin Capital, LLC portfolio as well as his latest detailed transactions.